Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Magnetic imaging agent
Patent
1994-03-28
1996-03-05
Hollinden, Gary E.
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Magnetic imaging agent
424 9322, 424646, 424648, 436173, A61B 5055
Patent
active
054965349
DESCRIPTION:
BRIEF SUMMARY
BACKGROUND OF THE INVENTION
This invention relates to the use of magnetic substances, in particular ferromagnetic and ferrimagnetic substances, as enhancing agents for diagnostic magnetometery, and in particular as contrast agents in magnetometric imaging, especially using a superconducting quantum interference device magnetometer (a SQUID), preferably in combination with a magnetic resonance imager.
In 1963 James Zimmerman, a researcher at Ford Motor Company, observed that when a non-superconducting boundary is present in a superconducting loop a special effect is created. This effect is extremely sensitive to magnetic flux and based on Zimmerman's work the very highly sensitive SQUID magnetometers have been developed and are now available commercially from companies such as Biomagnetic Technologies Inc of San Diego, Calif. and Siemens AG of Germany.
SQUID magnetometers generally comprise a superconducting pick up coil system and a detector system (the SQUID) which itself comprises one or two Josephson junctions inserted into a loop of superconducting wire. The magnetic flux within such loops is quantized and changes in the magnetic field experienced by the pick up coils cause an immediate and measurable change in the current flowing through the detector. The SQUID magnetometers available include both single and multichannel devices, the latter being capable of detecting magnetic fields at plurality of locations simultaneously.
SQUID magnetometers are capable of measuring magnetic fields as low as 10.sup.-14 Tesla, one ten billionth the earth's magnetic field, and thus are able to detect magnetic fields generated by biological activity such as for example the fields of the order of 10.sup.13 T which are induced by the electrical activity of the brain. The sources of nerve signals can thus be traced to within a few millimeters.
SQUIDS and their use in the study of biomagnetism are discussed for example by Wolsky et al. Scientific American, February 1989, pages 60-69, Philo et al. Rev. Sci. Instrum. 48:1529-1536 (1977), Cohen IEEE Trans. Mag. MAG-11(2):694-700 (1975), Farrell et al. Applied Physics Communications 1(1):1-7 (1981), Farrell et al. IEEE Trans. Mag. 16:818-823 (1980), and Brittenham et al. N. Eng. J. Med. 307(27):1671-1675 (1982). The SQUID may be designed to detect the magnetic field or, may be of the gradiometer type and which several designs exist.
Indeed the development of biomagnetic analysis has been closely linked to the development of SQUID detectors since conventional magnetometers, such as Bartington detectors or Hall-probe gaussmeters, are several orders of magnitude less sensitive to magnetic field changes.
In the study of biomagnetism, or more specifically, the in vivo measurement of magnetic susceptibility, the sensitivity of SQUIDS has been such that the researchers' concentration has primarily been on three areas--the detection of electrical activity within body tissues by detection of the accompanying magnetic field changes, the in vivo determination of iron concentrations in the liver in order to detect iron overload or iron deficiency there, and the detection of ferromagnetic particle contamination in the lungs.
In the first two cases, the magnetic fields detected by the SQUIDS arise from normal or stimulated nerve activity or from the normal presence of (paramagnetic) iron in the liver. In the third case, particle contamination is by magnetic particles, e.g. of magnetite, and their magnetic effect is first maximized by placing the subject in a magnetic field. The resultant magnetization is detectable by a SQUID for the period of months over which it decays.
Due to the extreme sensitivity of the SQUID technology enabling the body's electrical activity to be monitored, there has been little emphasis on the use of SQUIDS for the generation of images, in particular two or three dimensional images, of the body's internal physical structure rather than electrical activity images.
For such localisation to be effective it must be possible to generate magnetic susceptibility differen
REFERENCES:
patent: 4452773 (1984-06-01), Molday
patent: 4615879 (1986-10-01), Runge et al.
patent: 4675172 (1987-06-01), Widder
patent: 4735796 (1988-04-01), Gordon
patent: 4813399 (1989-03-01), Gordon
patent: 4827945 (1989-05-01), Groman et al.
patent: 4863715 (1989-09-01), Jacobsen et al.
patent: 4996991 (1991-03-01), Gordon
patent: 5384109 (1995-01-01), Klaveness et al.
Cofield et al., Chemical Abstracts, 104:217805s (1986).
Day et al., Biophys. J., 52, Nov. 1987, pp. 837-853.
Sundfors et al., J. de Phys., Coll. C10, 46:C10.785 (1985).
Swithenby, Phys. Technol., 18, pp. 17-24 (1987).
Farrell et al., Biomagnetism, Walter de Gruyter, Berlin 1981, pp. 507-518.
Fischer et al., 7th Int. Conf. on Biomagnetism, New York (Aug. 1990), pp. 285-286.
Farrell et al., IEEE Transactions on Magnetics, MAG-16, 5 pp. 818-823 (1980).
Cohen, IEEE Transactions on Magnetics, MAG-11, 2, pp. 694-700 (1975).
Ege Thorfinn
Klaveness Jo
Rocklage Scott M.
Hollinden Gary E.
Nycomed Imaging AS
LandOfFree
Squid magnetometry using ferri-and ferromagnetic particles does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Squid magnetometry using ferri-and ferromagnetic particles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Squid magnetometry using ferri-and ferromagnetic particles will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1411099